학술논문

A 3-year interval is too short for re-screening women testing negative for human papillomavirus: a population-based cohort study.
Document Type
Journal Article
Source
BJOG: An International Journal of Obstetrics & Gynaecology. Sep2017, Vol. 124 Issue 10, p1585-1593. 9p.
Subject
*PAPILLOMAVIRUS disease diagnosis
*DIAGNOSIS of diseases in women
*MEDICAL screening
*POPULATION-based case control
*COHORT analysis
*CERVIX uteri
*COLPOSCOPY
*COMPARATIVE studies
*LONGITUDINAL method
*RESEARCH methodology
*MEDICAL cooperation
*MEDICAL referrals
*MENTAL health surveys
*PAP test
*PAPILLOMAVIRUS diseases
*PAPILLOMAVIRUSES
*RESEARCH
*TIME
*EVALUATION research
*PREDICTIVE tests
*EARLY detection of cancer
*DISEASE complications
*DIAGNOSIS
CERVIX uteri tumors
Language
ISSN
1470-0328
Abstract
Objective: To compare the results from an initial negative human papillomavirus (HPV) test with re-screening after 3 years in women attending two HPV-based screening programmes.Design: Population-based cohort study.Setting: Two cervical service screening programmes in Italy.Population: Women aged 25-64 years invited to screening from April 2009 to October 2015.Methods: Eligible women were invited to undergo an HPV test. Those with a negative HPV test went on to the next screening round 3 years later. Cytology triage was performed for HPV+ (HPV by Hybrid Capture 2) samples, with immediate colposcopy (if abnormal) and HPV re-testing 1 year later (if negative).Main Outcome Measures: Participation rate, positivity at HPV and at triage, referral rate to colposcopy, positive predictive value for cervical intraepithelial neoplasia grade 2+ (CIN2+) at colposcopy, and detection rate for CIN2+.Results: We present the results from 48 751 women at the first screening and 22 000 women at re-screening 3 years later. The response rate was slightly higher at the second screening (74.5 versus 72.1% at the first screening; referral rate, RR 1.11; 95% confidence interval, 95% CI, 1.07-1.14). Compared with the first screening, we observed a significant reduction at the second screening in terms of HPV positivity (RR 0.55, 95% CI 0.51-0.60), referral rate to colposcopy (RR 0.47, 95% CI 0.41-0.53), CIN2+ detection rate (RR 0.24, 95% CI 0.13-0.39), and positive predictive value (PPV) for CIN2+ at colposcopy (RR 0.51, 95% CI 0.29-0.87).Conclusions: The very low frequency of disease and inadequate PPV at colposcopy indicate that a 3-year interval after a negative HPV test is too short.Tweetable Abstract: Three years after a negative HPV the frequency of cervical disease is so low that re-screening is inefficient. [ABSTRACT FROM AUTHOR]